Biochemical detection chips

Microfluidic-based diagnostic platforms for biochemical analysis and metabolite detection in clinical and research settings.

Microfluidic diagnostic chips designed for precise detection and diagnosis of tumors, infectious diseases, chronic conditions, and genetic disorders. These chips integrate microfluidic technology with multiple analytical platforms including fluorescent PCR, isothermal amplification, and immunoassay for applications in cancer screening, disease diagnosis, and therapeutic monitoring.

Biosensor chips for point-of-care diagnostics and laboratory testing. These chips enable rapid detection of biomarkers through microfluidic technology, supporting applications in disease screening, glucose monitoring, and clinical analysis. Designed for integration into diagnostic platforms requiring real-time measurement capabilities.

Advanced microfluidic devices for molecular diagnostics including nucleic acid analysis and genetic testing applications.

Integrated microfluidic solutions designed for immunological diagnostic assays, supporting rapid and accurate detection of biomarkers and antigens.

Microfluidic biochips designed for liquid biopsy applications, enabling non-invasive detection of circulating biomarkers for cancer and disease diagnostics. The chips integrate sample preparation, separation, and detection capabilities in a compact format, supporting rapid analysis with minimal sample volumes for clinical screening and monitoring.

Microfluidic biochips specifically engineered for liquid biopsy applications, enabling detection and analysis of circulating biomarkers. These chips support early disease detection and monitoring through minimally invasive sampling.

Microfluidic blood analysis chips for point-of-care white blood cell differentiation and classification. These disposable chips replace traditional fluid pathway systems in portable hematology analyzers, enabling rapid 1-minute detection of bacterial/viral infections and immune status assessment in clinical, diagnostic, and field settings.

Microfluidic chips for performing immunoassays with reduced sample and reagent volumes, providing rapid results for clinical diagnostics.

POCT (Point-of-Care Testing) microfluidic chips enable rapid diagnostic testing at the patient bedside or clinical setting. These biochips integrate sample preparation, reagent delivery, and detection in a single disposable device, supporting applications in clinical diagnostics, infectious disease screening, and rapid biomarker detection. The chips feature microfluidic channel architecture with integrated biological surface modifications for enhanced assay performance.

BioChips Reaction (BCR) platform for early diagnosis and timely treatment of diseases. Utilizes biochip technology to enable rapid, accurate diagnostic testing. Designed for clinical laboratories and diagnostic facilities requiring advanced molecular analysis capabilities.

Microfluidic biochips designed for point-of-care testing applications. These chips enable rapid diagnostic analysis with minimal sample volumes, supporting quick clinical decision-making in various healthcare settings.